Search
-
Health and Wellness: Data, insights, and solutions
What do people want from their health and their healthcare? And from telehealth to public health policy, how is that changing? Here’s Ipsos’ top insights on these issues and others.
-
Retail, food, and beverage: Essential data and insights
From subscription services and e-commerce to tariffs and boycotts, the ways we shop and spend are in flux. Here’s Ipsos’ top data and analysis on what you need to know.
-
Low awareness of GLP-1s globally, but high in the most advanced economies
Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.
-
Insights to Activate
Insights to Activate is a monthly series exploring a range of timely topics, featuring impactful insights that you can activate tomorrow.
-
Who will guide our future wellness in a post-trust world?
Trust is crucial for public health, but it’s eroding. What the Future Editor Matt Carmichael outlines key challenges and questions for business leaders and policymakers to effectively promote wellness and navigate the evolving health landscape.
-
Why food companies must act together to reshape America’s food landscape
Nutrition and food policy expert Marion Nestle breaks down how the food landscape has changed over the last two decades, and industry changes she thinks will chart a healthier future.
-
Questions for the future
From an aging population to artificial intelligence, these are the crucial health and wellness questions that leaders in public health, women’s health, technology, aging and consumer health need to consider to prepare for the future.
-
Ipsos launches GLP-1 PersonaBot, designed to support companies’ understanding of the consumer obesity treatment market
Ipsos’ latest AI-powered innovation offers unparalleled insights into the fast-moving consumer obesity treatment market – while reinforcing Ipsos’ position at the forefront of AI applications in market research.
-
Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
GLP-1s are more than just weight loss drugs. They're a chance to rewrite our evolutionary story, to take control of our biology in a way never before possible.